
浏览全部资源
扫码关注微信
河南省中医院,郑州 450009
张辉果,硕士,主治医师,从事中医儿科疾病研究,Tel:0371-60908747,E-mail:zhanghuiguo2@163.com
修回日期:2020-05-07,
网络出版日期:2020-05-22,
纸质出版日期:2020-08-05
移动端阅览
张辉果,董志巧,王晓利等.漏芦升麻汤联合阿奇霉素对邪热壅肺型支原体肺炎患儿调节性T细胞及Foxp3 mRNA表达的影响[J].中国实验方剂学杂志,2020,26(15):90-96.
ZHANG Hui-guo,DONG Zhi-qiao,WANG Xiao-li,et al.Efficacy of Loulu Shengma Tang Combined with Azithromycin in Treating Children with Mycoplasma Pneumonia with Obstruction of Lung by Pathogenic Heat and Its Effect on Treg and Foxp3 mRNA[J].Chinese Journal of Experimental Traditional Medical Formulae,2020,26(15):90-96.
张辉果,董志巧,王晓利等.漏芦升麻汤联合阿奇霉素对邪热壅肺型支原体肺炎患儿调节性T细胞及Foxp3 mRNA表达的影响[J].中国实验方剂学杂志,2020,26(15):90-96. DOI: 10.13422/j.cnki.syfjx.20201524.
ZHANG Hui-guo,DONG Zhi-qiao,WANG Xiao-li,et al.Efficacy of Loulu Shengma Tang Combined with Azithromycin in Treating Children with Mycoplasma Pneumonia with Obstruction of Lung by Pathogenic Heat and Its Effect on Treg and Foxp3 mRNA[J].Chinese Journal of Experimental Traditional Medical Formulae,2020,26(15):90-96. DOI: 10.13422/j.cnki.syfjx.20201524.
目的
2
探讨漏芦升麻汤联合阿奇霉素治疗小儿邪热雍肺型小儿支原体肺炎(MPP)的临床疗效,以及对患儿调节性T细胞及核转录因子叉状头/翅膀状螺旋转录因子3(Foxp3) mRNA表达的影响。
方法
2
将274例MPP患儿随机分为观察组与对照组,每组各137例。观察组给予漏芦升麻汤联合阿奇霉素干混悬剂治疗,对照组单独给予阿奇霉素干混悬剂治疗。观察两组患儿治疗后体征、临床症状消失时间、中医邪热雍肺证评分、血清炎症因子白细胞介素-6(IL-6),白细胞介素-10(IL-10),肿瘤坏死因子-
α
(TNF-
α
),C反应蛋白(CRP),CD4
+
CD25
+
Treg和CD4
+
Foxp3
+
Treg及Foxp3 mRNA表达水平变化情况。比较两组患儿的临床疗效及不良反应发生率。
结果
2
治疗后观察组总有效率94.16%(129/137),高于观察组(77.37%,106/137)(
P
<
0.05);观察组患儿治疗后咳嗽、肺部啰音的消失时间、退热时间及X射线检查肺部阴影消失时间均短于对照组(
P
<
0.05);治疗后观察组中医邪热雍肺证评分的改善情况优于对照组(
P<
0.05);治疗后观察组血清IL-6,IL-10,TNF-
α
和CRP水平较对照组降低明显(
P
<
0.05,
P
<
0.01),观察组CD4
+
CD25
+
Treg,CD4
+
Foxp3
+
Treg及Foxp3 mRNA表达水平明显高于对照组(
P
<
0.05)。不良反应的发生率观察组(7/137,5.11%)低于对照组(16/137,11.68%)。
结论
2
漏芦升麻汤联合阿奇霉素干混悬剂治疗小儿邪热雍肺型MPP的临床疗效明显,可明显改善患儿病证,对患儿调节性T细胞及Foxp3 mRNA表达的影响优于单用阿奇霉素干混悬剂,具有效性,且不良反应的发生率较单用阿奇霉素干混悬剂低。
Objective
2
To investigate the clinical efficacy of Loulu Shengma Tang combined with azithromycin in the treatment of pediatric mycoplasma pneumoniae pneumonia(MPP) with obstruction of lung by pathogenic heat, and its effect on inflammatory factors, treg and Foxp3 mRNA.
Method
2
Totally 274 children with MPP were divided into observation group (137 cases) and control group (137 cases). Observation group was treated with Loulu Shengma Tang combined with azithromycin dry suspension, while control group was treated with azithromycin dry suspension alone. The changes of traditional Chinese medicine(TCM) syndrome score of pathogenic-heat obstruction in the lung, serum inflammatory cytokines [interleukin-6 (IL-6),interleukin-10 (IL-10),tumor necrosis factor-
α
(TNF-
α
),C-reactive protein (CRP)], CD4
+
CD25
+
Treg, CD
4
+
Foxp3
+
Treg and Foxp3 mRNA expressions were observed after treatment. The clinical efficacy and the incidence of adverse reactions were compared between two groups.
Result
2
The total effective rate of observation group was 94.16%(129/137) after treatment, which was significantly higher than 77.37% (106/137)of observation group (
P
<
0.05). The disappearance times of cough, lung rale, fever and lung shadow in observation group were shorter than that in control group (
P
<
0.05). After treatment, TCM syndrome score of pathogenic-heat obstruction in lung was significantly higher than those in control group (
P
<
0.05), serum IL-6, IL-10, TNF-
α
and CRP levels in observation group were significantly lower than those in control group (
P
<
0.05,
P
<
0.01), while CD4
+
CD25
+
Treg, CD
4
+
Foxp3
+
Treg and Foxp3 mRNA expressions were significantly higher than those in control group (
P
<
0.05). The incidence of adverse reactions in observation group was 7/137 (5.11%), which was significantly lower than 16/137 (11.68%) in control group.
Conclusion
2
The clinical efficacy of Loulu Shengma Tang combined with azithromycin dry suspension in the treatment of pediatric MPP and its effect on serum inflammatory factors (IL-6, IL-10, TNF-
α
, CRP), regulatory T cells and Foxp3 mRNA expressions were better than those of azithromycin dry suspension alone. The incidence of adverse reactions of Loulu Shengma Tang was lower than that of azithromycin dry suspension alone.
郭清 , 韩登高 . 肺痈宁方辅助治疗对肺炎支原体肺炎患儿早期血清中sIL-2R、IL-6与外周血单个核细胞SOCS3表达的影响 [J]. 中药材 , 2016 , 39 ( 7 ): 1664 - 1666 .
陈团营 , 朱珊 , 边红恩 , 等 . 连花清瘟颗粒对小儿肺炎支原体肺炎肺功能指标、血清炎症因子水平影响及疗效分析 [J]. 中华中医药学刊 , 2018 , 36 ( 11 ): 2713 - 2715 .
林坚 , 许志有 , 邢东文 . 痰热清注射液联合阿奇霉素治疗小儿支原体肺炎的疗效及对炎症因子的影响 [J]. 中华中医药学刊 , 2017 , 35 ( 9 ): 2418 - 2420 .
王丹 . 清肺饮合槐杞黄颗粒治疗小儿支原体肺炎(痰热闭肺型)的临床疗效评价 [D]. 长春 : 长春中医药大学 , 2018 .
陈弘韬 . 风热方配合肺炎贴治疗小儿支原体肺炎风热闭肺证的临床观察 [D]. 福州 : 福建中医药大学 , 2018 .
SONG Q , XU B P , SHEN K L . Bacterial co-infection in hospitalized children with mycoplasma pneumoniae Pneumonia [J]. Indian Pediatr , 2016 , 53 ( 10 ): 879 - 882 .
沈彩红 , 刘云 , 余宪文 , 等 . 茜草醇提物对佐剂性关节炎大鼠肝脏、脾脏损伤及Foxp3的影响 [J]. 中国实验方剂学杂志 , 2018 , 24 ( 7 ): 147 - 153 .
胡亚美 , 江载芳 . 诸福棠实用儿科学 [M]. 7 版 .北京 : 人民卫生出版社 , 2002 : 1204 - 1205 .
朱文锋 . 国家标准应用-中医内科疾病诊疗常规 [M]. 长沙 : 湖南科学技术出版社 , 1999 : 272 - 279 .
郑锋 , 陆凤娟 , 徐颖 , 等 . 双黄连颗粒联合阿奇霉素干混悬剂治疗小儿支原体肺炎的临床疗效观察 [J]. 中药材 , 2015 , 38 ( 2 ): 416 - 418 .
廖震 , 楼凌云 . 小儿肺咳颗粒辅助治疗儿童支原体肺炎的疗效及其对血清活化蛋白C和白介素1受体1型水平的影响 [J]. 中国妇幼保健 , 2018 , 33 ( 2 ): 369 - 371 .
钟红平 , 王宽锋 , 刘世平 . 蛇胆川贝液治疗小儿难治性支原体肺炎的临床疗效观察 [J]. 中药药理与临床 , 2017 , 33 ( 2 ): 192 - 194 .
罗玉君 , 温晓莹 , 倪晓良 , 等 . 喜炎平注射液联合阿奇霉素治疗小儿支原体肺炎疗效及安全性的Meta分析 [J]. 中国中药杂志 , 2018 , 43 ( 10 ): 2153 - 2161 .
徐志立 , 张莹 , 陶小军 , 等 . 中药与抗感染西药联用中的增效减毒相互作用 [J]. 时珍国医国药 , 2017 , 28 ( 1 ): 202 - 204 .
张宁 . 儿童肺炎支原体肺炎合并腺病毒感染的证治研究 [D]. 济南 : 山东中医药大学 , 2015 .
陈棉 , 王伟杰 , 谢维维 , 等 . 支气管肺炎患儿IL-6、IL-8、CRP等感染标志物的变化及临床意义分析 [J]. 中华医院感染学杂志 , 2016 , 26 ( 18 ): 4207 - 4209 .
苑伟 , 杨慧 , 谢勇 , 等 . 连翘酯苷A对全身内毒素血症小鼠调节性T细胞的影响 [J]. 中成药 , 2014 , 36 ( 8 ): 1584 - 1588 .
刘桂兰 . 肺炎支原体肺炎患儿血清IL-37、IL-18水平变化的研究 [D]. 南昌 : 南昌大学第一附属医院 , 2015 .
柯胜忠 , 张多 , 张洪雷 . 加味千金苇茎汤对小儿支原体肺炎患儿调节性T细胞及其相关蛋白Foxp3表达的影响 [J]. 中医学报 , 2018 , 33 ( 8 ): 1388 - 1391 .
周奕辰 , 王金岩 . CD4 + CD25 + Treg细胞在小鼠Lewis肺癌生长及转移中的作用 [J]. 中国免疫学杂志 , 2019 , 35 ( 14 ): 1712 - 1716 .
0
浏览量
14
下载量
1
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621